<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">Antiphospholipid syndrome</z:e> is an <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> characterized pathophysiologically by the presence of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> and &gt; or =1 clinical manifestation, the most common being venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We describe the case of a 40-year-old male with unexplained severe pulmonary arterial <z:hpo ids='HP_0000822'>hypertension</z:hpo> with a seven-day history of progressive <z:mp ids='MP_0001954'>shortness of breath</z:mp>, <z:hpo ids='HP_0002105'>hemoptysis</z:hpo>, chest discomfort and bilateral pedal <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Electrocardiographic, echocardiographic and imaging studies showed changes consistent with <z:hpo ids='HP_0011010'>chronic</z:hpo> thromboembolic <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Further work-up showed positive anticardiolipin antibodies and <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> with negative features for <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> with negative primary thrombophilic studies as well </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was managed adequately with oral anticoagulation with improvement of his clinical status and referred to a tertiary care center to be screened for pulmonary thromboendarterectomy </plain></SENT>
<SENT sid="5" pm="."><plain>For patients meeting surgical selection criteria, pulmonary thromboendarterectomy has demonstrated positive outcomes with respect to survival, functionality and quality of life </plain></SENT>
<SENT sid="6" pm="."><plain>We discuss the pathophysiology and treatment as well as novel therapies in nonsurgical candidates with <z:hpo ids='HP_0011010'>chronic</z:hpo> thromboembolic <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> in the setting of <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>